Phase II Trial of Preoperative Combined Modality Therapy for Esophageal Carcinoma: Cisplatin-Irinotecan Followed by Radiation Therapy With Concurrent Cisplatin and Irinotecan.
Clinical trial NCT00590031 · COMPLETED
Trial details
- NCT number
- NCT00590031
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-11-01
- Primary completion
- 2009-12-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.